Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

New England Journal of Medicine - Tập 355 Số 24 - Trang 2542-2550 - 2006
Alan Sandler1, Robert J. Gray2, Michael C. Perry3, Julie R. Brahmer4, Joan H. Schiller5, Afshin Dowlati6, Rogério Lilenbaum7, David H. Johnson1
1Vanderbilt University, Nashville
2Dana Farber Cancer Institute, Boston
3Ellis Fischel Cancer Center, University of Missouri, Columbia
4Johns Hopkins University, Baltimore
5University of Wisconsin, Madison
6University Hospitals of Cleveland, Cleveland
7Mount Sinai Hospital, Miami

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.3322/canjclin.55.1.10

10.1056/NEJMoa011954

10.1016/S0092-8674(00)81683-9

10.1093/jnci/82.1.4

10.1007/BF00666035

10.1038/bjc.1996.166

Brown LF, 1993, Cancer Res, 53, 4727

10.1016/0046-8177(95)90119-1

10.1016/j.lungcan.2006.02.009

10.1038/nm0603-669

10.1038/362841a0

Kabbinavar FF, 1995, Proc Am Assoc Cancer Res, 36, 488

Borgstrom P, 1999, Anticancer Res, 19, 4203

10.1056/NEJMoa032691

10.1200/JCO.2004.11.022

10.1093/jnci/91.6.523

Jennison C, 1989, J R Stat Soc [B], 51, 305

10.1038/nm0901-987

10.1038/nm988

Giantonio BJ, 2005, J Clin Oncol, 23, 16S, 10.1200/jco.2005.23.16_suppl.2

Miller KD, 2005, Breast Cancer Res Treat, 94, S6

Kozloff M, 2005, J Clin Oncol, 23, 16S, 10.1200/jco.2005.23.16_suppl.3566

10.1200/JCO.2005.01.5388